Changes in biochemical parameters related to lipid metabolism following lithium treatment in rat

Iranian Biomedical Journal

Volumn 9, Issue 1, 2005, Pages 27-32

  Ani, Mohsen ^a   Moshtaghie, Ali Asghar ^a   Akbarzadeh, Samad ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Fat cell lipolysis; Lipid parameters; Lithium; Rat

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CITRIC ACID; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN LIPASE; LITHIUM CHLORIDE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID; TRIACYLGLYCEROL;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INHIBITION; EPIDIDYMIS FAT; LIPID BLOOD LEVEL; LIPID LIVER LEVEL; LIPID METABOLISM; LIPOLYSIS; LIPOPROTEIN METABOLISM; MALE; NONHUMAN; RAT;

ANIMALIA; RATTUS NORVEGICUS;

EID: 16244407123     PISSN: 1028852X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Koffman, O., Belmaker, R.H., Grisaru, N., Alpert, C., Fuchs, I., Katz, V. and Rigler, O. (1991) Myoinositol attenuates two specific behavioral effects of acute lithium in rats. Psychopharmacol. Bull. 27 (3): 185-190.
2. Rapoport, S.I. and Bosetti, F. (2002) Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorders. Arch. Gen. Psychiatry 59 (7): 592-596.
3. Duffy, C. and Kane, M.T. (1996) Investigation of the role of inositol and the phosphatidyl inositol signal transduction system in mouse embryonic stem cells. J. Reprod. Fertil. 108 (1): 87-93.
4. Atack, J.R. (1996) Inositol monophosphatase, the putative therapeutic target for lithium. Brain Res. Rev. 22: 183-190.
5. Lee, C.H., Dixon, J.F., Reichman, M., Moummi, C., Los, G. and Hokin, L.E. (1992) Lithium increases accumulation of inositol 1, 4, 5-triphosphate and inositol 1, 3, 4, 5-tetrakis phosphate in cholinergically stimulated brain cortex slices in guinea pig, mouse and rat. Biochem. J. 282: 377-385.
6. Godfrey, P.P., McClue, S.J., White, A.M., Wood, A.J. and Grahame-Smith, D.G. (1989) Subacute and chronic in vivo lithium treatment inhibits agonist and sodium fluoride-stimulated inositol phosphate production in rat cortex. J. Neurochem. 52: 498-506.
7. Belmaker, R.H. (1981) Receptor, adenylate cyclase, depression and lithium. Biol. Psychiat. 16: 333-350.
8. Zawalich, W.S., Zawalich, K.C. and Rasmussen, H., (1989) Interaction between lithium, inositol and mono-oleoglycerol in the regulation of insulin secretion from isolated perfused rat islets. Biochem. J. 262: 557-561.
9. Newman, M.E. and Lerer, B. (1988) Effects of lithium and desipramine administration on agonist-stimulated inositol phosphate accumulation in rat cerebral cord. Biochem. Pharmacol. 37:1991-1995.
10. Batty, I. and Stefan, R.N. (1985) Differential effects of lithium on muscarinic receptor simulation of inositol phosphates in rat cerebral cortex slices. J. Neurochemistry 42: 1514-1521.
11. Detera-Wadleigh, S.D. (2001) Lithium-related genetics of bipolar disorders. Ann. Med. 33 (4): 272-285.
12. Zetin, M. (2004) Psychopharmacohazardology: major hazards of the new generation of psychotherapeutic drugs. International J. Clin. Practice. 58 (1): 58-79.
13. Weirzbicki, A.S., Hardman, T.C., Cheung, J., Patel, M., Smallberger, S., Lumb, P.J. and Lant, A.F. (2001) Relation between sodium-lithium counter transporter and hypertriglyceridemia in type V hyper lipidemia. Am. J. Hypertension (14): 32-37.
14. Soares, J.C., Mallinger, A.G., Dippold, C.S., Forster Wells, K., Frank, E. and Kupter, D. J. (2000) Effect of lithium on platelet membrane phosphoinositides in bipolar disorder patients. Psychopharmacology (Berl) 149 (1): 12-16.
15. Korn, E.D. (1962) Lipoprotein lipase, clearing factor. In: Methods in Enzymology. Vol. 5, (Colowick, S.P. and Kaplan, N.O. eds.), Academic press, New York, London, pp. 542-545.
16. nd ed., Academic press, London, pp. 819-827.
17. Lowry, O.H., Rosenbrough, N.J., Forr, A.L. and Randall, R.J. (1951) Protein measurement with the folin-phenol reagent. J. Biol. Chem. 193: 256-275.
18. Warnick, G.R., Cheung, M.C. and Albers, J.J. (1979) Comparison of current methods for HDL quantification. Clin. Chem. 25: 596-601.
19. Friedewald, W.T., Levy, R.I. and Fredrickson, D.S. (1972) Estimation of the concentration of LDL-C in plasma without use of the preparative ultracentrifuge. Clin. Chem. 18: 499-502.
20. Fiske, C.H. and Subbarow, Y. (1925) Colorimetric determination of phosphorus. J. Biol. Chem. 66: 357-400.
21. Rodbell, M. (1966) Metabolism of isolated fat cells. J. Biol. Chem. 239 (2): 375-380.
22. Radin, N.S. (1969) Preparation of lipid extracts. In: Methods in Enzymology. Vol. 14, (Lowenstein, J.M. ed.), Academic Press, New York, London. PP. 245-249.
23. Park, A. and Juny, D.H. (1989) Serum lipids. In: Clinical laboratory methods, (Bauer J.D. and Mosby Coeds.), Toronto. 548-549.
24. Ani, M., Moshtaghie, A.A. and Valian, S. (1996) Changes in the plasma levels of lipid fractions and lipoprotein lipase activity following aluminium administration. Clin. Chem. Enz. Comms. 7: 81-92.
25. Aiwen, P., Leibman, A. and Zweier, J. (1937) Stoichiometric and site characteristics of the binding site of iron to human transferrin. J. Biol. Chem. 1930-1937.
26. Kerry, R.J. (1975) The management of patients receiving lithium treatment. In: Lithium research and therapy. (Johnson, F.N. ed.), Academic press, New York, London, pp. 143-163.
27. Tornqvist, H. and Belfrage, P. (1976) Purification and some properties of monoacylglycerol-hydrolysins enzyme of rat adipose tissue. J. Biol. Chem. 251: 813-819.
28. Mulder, M. and Stenson, L. (1999) Hormone Sensitive lipase, the rate limiting step enzyme in triglycerids hydrolysis. Diabetes 48: 228-232.
29. Ebstein, R.P., Hermoni, M. and Belmaker, R.H. (1980) The effect of lithium on noradrenaline induced cAMP accumulation in rat brain. J. Pharmacol. Exp. Ther. 213: 161-162.
30. Husseini, K., Manji, J. and Bitran, A. (1991) Signal transduction modulation by lithium. Psychopharmachol. Bull. 27 (3): 199-208.
31. Lenox, R.H. and Hahn, C.G. (2000) Over view of the mechanism of action of lithium in the brain: fifty years update. J. Clin. Psychiatry 81: 5-15.
32. Cobbold, C.A., Sherratt, J.A. and Maxwell, R.J. (2002) Lipoprotein oxidation and its significance for atherosclerosis. Bull. Math. Biol. 64: 65-95.
33. Parthasarathy, S., Barnett, J. and Fong, L.G. (1990) High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochem. Biophys. Acta. 1044: 275-283.
34. Tall, A.R. (1990) Plasma high-density lipoproteins: metabolism and relationship to atherosclerosis. J. Clin. Invest. 86: 379-384.
35. Bonnefont-Rousselot, D. and Therond, J. (1999) HDL and the oxidative hypothesis of atherosclerosis. Clin. Chem. Lab. Med 37: 939-948.
36. Mellerup, E.T. and Rafaelsen, O.J. (1975) Lithium and carbohydrate metabolism. In: lithium research and therapy. (Johnson, F.N. ed.), Academic press, New York, London, pp. 381-390.
37. Bramham, J. and Riddell, F.G. (1995) The effect of lithium therapy upon the composition of the human erythrocyte membrane. J. Inorganic Biochem 57 (1): 23-32.